Market Cap 5.19M
Revenue (ttm) 8.01M
Net Income (ttm) -7.13M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -89.01%
Debt to Equity Ratio -3.24
Volume 1,645,000
Avg Vol 19,388,145
Day's Range N/A - N/A
Shares Out 11.28M
Stochastic %K 33%
Beta 1.59
Analysts Hold
Price Target $1.00

Latest News on RSLS

ReShape Lifesciences Announces 1-for-58 Reverse Stock Split

Sep 19, 2024, 8:31 AM EDT - 7 months ago

ReShape Lifesciences Announces 1-for-58 Reverse Stock Split